Arbutus Biopharma (ABUS) Exchange Rate Effect (2013 - 2026)
Arbutus Biopharma (ABUS) posted quarterly Exchange Rate Effect of -$10000.0 for Q1 2026, down 350.0% year-on-year from $4000.0 in Q1 2025, and down 1100.0% on a QoQ basis from $1000.0 in Q4 2025.
Arbutus Biopharma (ABUS) Exchange Rate Effect (2013 - 2026) Analysis & Trends
Arbutus Biopharma (ABUS) has reported Exchange Rate Effect for 14 consecutive years, with -$10000.0 the latest figure, recorded in Q1 2026.
- Quarterly Exchange Rate Effect fell 350.0% year-over-year to -$10000.0 in Q1 2026, while the trailing twelve-month figure through Dec 2025 was $14000.0 (up 128.57% YoY) and the FY2025 annual result came in at $14000.0, up 128.57% from the prior year.
- Exchange Rate Effect retreated to -$10000.0 in Q1 2026 per ABUS's latest filing, from $1000.0 in the prior quarter.
- Over the last five years, Exchange Rate Effect for ABUS reached as high as $21000.0 in Q2 2025 and fell as low as -$33000.0 in Q4 2024.
- A 5-year average of -$2800.0 and a median of -$1000.0 in 2023 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2023 — Exchange Rate Effect jumped 450.0% — and 2024, when it sank 700.0%.
- Year by year, Exchange Rate Effect stood at -$4000.0 in 2022, then soared by 450.0% to $14000.0 in 2023, then slumped by 335.71% to -$33000.0 in 2024, then jumped by 103.03% to $1000.0 in 2025, then sank by 1100.0% to -$10000.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$10000.0, $1000.0, and -$12000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Arbutus Biopharma | 880.36 Mn | 785.13 Mn | - | -10,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10,000.00 |
| Mar 31, 2026 | -10,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | -12,000.00 |
| Sep 30, 2025 | -12,000.00 |
| Jun 30, 2025 | 21,000.00 |
| Jun 30, 2025 | 21,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | -33,000.00 |
| Dec 31, 2024 | -33,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Jun 30, 2024 | -8,000.00 |
| Jun 30, 2024 | -8,000.00 |
| Mar 31, 2024 | -13,000.00 |
| Mar 31, 2024 | -13,000.00 |
| Dec 31, 2023 | 14,000.00 |
| Dec 31, 2023 | 14,000.00 |